CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B Virus

相似書籍

• 7-Deaza-7-fluoro modification confers on 4’-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety
  由: Hayashi, Sanae, et al.
  出版: (2020)
• 4′-Modified Nucleoside Analogs: Potent Inhibitors Active against Entecavir-resistant Hepatitis B Virus
  由: Takamatsu, Yuki, et al.
  出版: (2015)
• DESIGN, SYNTHESIS, AND EVALUATION OF ANTI-HBV ACTIVITY OF HYBRID MOLECULES OF ENTECAVIR AND ADEFOVIR: EXOMETHYLENE ACYCLOGUANINE NUCLEOSIDES AND THEIR MONOPHOSPHATE DERIVATIVES
  由: Imoto, Shuhei, et al.
  出版: (2015)
• A novel entecavir analogue constructing with a spiro[2.4]heptane core structure in the aglycon moiety: Its synthesis and evaluation for anti-hepatitis B virus activity
  由: Kumamoto, Hiroki, et al.
  出版: (2017)
• Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine
  由: Yasutake, Yoshiaki, et al.
  出版: (2020)